|
|
|
Transplant Statistics: Annual Report : Reference Tables
| Year of Transplant | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | ||
| Functioning Graft at Discharge | 2,451 | 2,798 | 3,062 | 3,343 | 3,438 | 3,581 | 3,934 | 4,085 | 4,325 | 4,614 | |
| With Immunosuppression Info | 2,450 | 2,793 | 3,043 | 3,300 | 3,291 | 3,382 | 3,650 | 3,769 | 4,167 | 4,394 | |
| Corticosteroids | Category Usage | 93.6% | 95.2% | 90.7% | 87.7% | 90.2% | 94.3% | 94.4% | 92.5% | 90.0% | 88.5% |
| Prednisone | 92.4% | 93.9% | 85.6% | 81.4% | 81.8% | 87.9% | 90.8% | 88.6% | 84.6% | 82.1% | |
| Methylprednisolone | 14.5% | 13.2% | 10.3% | 9.7% | 13.6% | 9.6% | 8.8% | 9.2% | 9.5% | 8.9% | |
| Cyclosporine | Category Usage | 81.6% | 83.2% | 64.5% | 47.2% | 41.2% | 38.5% | 31.6% | 26.5% | 19.0% | 11.9% |
| Cyclosporin | 81.6% | 83.0% | 62.4% | 39.8% | 5.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Sandimmmune | 0.7% | 1.1% | 1.8% | 3.0% | 6.8% | 4.4% | 4.1% | 3.9% | 3.1% | 1.4% | |
| Neoral | 0.1% | 0.0% | 1.3% | 5.8% | 30.6% | 34.9% | 27.8% | 22.8% | 16.0% | 9.5% | |
| Gengraf | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.7% | |
| Eon | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.4% | |
| Tacrolimus | Category Usage | 18.7% | 17.6% | 30.5% | 46.8% | 55.2% | 58.7% | 66.4% | 71.0% | 75.9% | 83.0% |
| FK506 | 18.7% | 17.6% | 30.5% | 46.8% | 55.2% | 58.7% | 66.4% | 71.0% | 75.9% | 83.0% | |
| Antimetabolites | Category Usage | 56.3% | 58.7% | 48.0% | 41.4% | 48.7% | 43.2% | 41.8% | 45.2% | 48.7% | 50.9% |
| Azathioprine | 56.3% | 58.3% | 47.2% | 35.5% | 26.2% | 18.9% | 11.2% | 7.3% | 4.9% | 3.1% | |
| Mycophenolate mofetil | 0.0% | 0.6% | 1.0% | 6.3% | 23.1% | 26.6% | 31.3% | 38.4% | 44.0% | 47.9% | |
| Other | Category Usage | 0.2% | 0.1% | 0.4% | 0.3% | 0.3% | 0.2% | 1.0% | 0.6% | 9.7% | 9.9% |
| Rapamycin | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.8% | 0.5% | 9.6% | 9.7% | |
| Cytoxan | 0.2% | 0.1% | 0.4% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | |
Center-Specific Reports | OPO Reports | National Reports | Data Accuracy | Report Timeline
Home | Who We Are | What We Do | About Transplants | Transplant Statistics | Research Resources | Contact Us | Site Map
SRTR Site designed and maintained by Diamond Bullet Design & URREA.